These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9038129)

  • 1. 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T.
    Reichenbach JR; Hackländer T; Harth T; Hofer M; Rassek M; Mödder U
    Eur Radiol; 1997; 7(2):264-74. PubMed ID: 9038129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agent.
    Adzamli K; Periasamy MP; Spiller M; Koenig SH
    Invest Radiol; 1999 Jun; 34(6):410-4. PubMed ID: 10353033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
    Shuter B; Tofts PS; Wang SC; Pope JM
    Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: a phantom study.
    Sasaki M; Shibata E; Kanbara Y; Ehara S
    Magn Reson Med Sci; 2005; 4(3):145-9. PubMed ID: 16462135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
    Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
    AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two new gadolinium chelates as contrast agents for MRI.
    Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
    Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of T1-enhancing and magnetic susceptibility magnetic resonance contrast agents for demarcation of the jeopardy area in experimental myocardial infarction.
    Yu KK; Saeed M; Wendland MF; Dae MW; Velasquez-Rocha S; Derugin N; Higgins CB
    Invest Radiol; 1993 Nov; 28(11):1015-23. PubMed ID: 7506243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ni-DTPA doped agarose gel--a phantom material for Gd-DTPA enhancement measurements.
    Tofts PS; Shuter B; Pope JM
    Magn Reson Imaging; 1993; 11(1):125-33. PubMed ID: 8423715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudolayering of Gd-DTPA in the urinary bladder.
    Elster AD; Sobol WT; Hinson WH
    Radiology; 1990 Feb; 174(2):379-81. PubMed ID: 2296649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
    Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
    Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
    Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
    Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
    Nilsson S
    Acta Radiol Suppl; 1995; 397():1-44. PubMed ID: 7484207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High dosage Gd-DPTA-BMA (Gadodiamid) administration in diagnosis and therapeutic monitoring of malignant bone tumors].
    Häussler MD; Rummeny EJ; Raufhake C; Blasius S; Lindner N; Daldrup HE; Reimer P; Peters PE
    Radiologe; 1996 Feb; 36(2):148-52. PubMed ID: 8867432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation.
    Braunschweiger PG; Schiffer L; Furmanski P
    Magn Reson Imaging; 1986; 4(4):285-91. PubMed ID: 3118123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement.
    Kim TK; Choi BI; Han JK; Jang HJ; Han MC
    Acta Radiol; 1997 Jul; 38(4 Pt 1):565-71. PubMed ID: 9240679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
    Puttagunta NR; Gibby WA; Puttagunta VL
    Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI of human tumor xenografts in vivo: proton relaxation times and extracellular tumor volume.
    Jakobsen I; Lyng H; Kaalhus O; Rofstad EK
    Magn Reson Imaging; 1995; 13(5):693-700. PubMed ID: 8569443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1 and T2 measurements of meningiomas and neuromas before and after Gd-DTPA.
    Watabe T; Azuma T
    AJNR Am J Neuroradiol; 1989; 10(3):463-70. PubMed ID: 2546413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUR Memorial Award. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging.
    Geschwind JF; Wendland MF; Saeed M; Lauerma K; Derugin N; Higgins CB
    Acad Radiol; 1994 Dec; 1(4):319-25. PubMed ID: 9419506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The T2-shortening effect of gadolinium and the optimal conditions for maximizing the CNR for evaluating the biliary system: a phantom study.
    Lee MJ; Kim MJ; Yoon CS; Song SY; Park K; Kim WS
    Korean J Radiol; 2011; 12(3):358-64. PubMed ID: 21603295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.